Stock Events

Stock Events

BioArctic AB 

$36.92
25
+$2.87+8.44% Thursday 15:29

Statistics

Day High
35
Day Low
35
52W High
38.75
52W Low
27.82
Volume
250
Avg. Volume
11
Mkt Cap
2.74B
P/E Ratio
140
Dividend Yield
0.58%
Dividend
0.21

Upcoming

Dividends

0.58%Dividend Yield
Jun 26
$0.21
May 19
$0.16
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

25NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.12
0.3
0.72
1.15
Expected EPS
0.02484
Actual EPS
N/A

Financials

49.87%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
204.09MRevenue
101.78MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BRCTF. It's not an investment recommendation.
Microsoft
5
MSFT
Investor AB
5
INVE-B.ST
Volvo AB
4
VOLV-B.ST
Swedbank AB
4
SWED-A.ST

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of innovative biological drugs, such as antibodies that address high unmet medical needs. The company's therapeutic areas encompass neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and other CNS diseases. In addition, it owns a technology platform, which develops a range of therapeutic monoclonal antibodies. Additionally, the company is developing lecanemab, which is in phase 3 clinical trials; Lecanemab that is in back-up phase 3 clinical trials; Exidavnemab, which is in phase 2 clinical trials; Lecanemab, BAN2803, and BAN2802 that are in preclinical trials; and BAN1503, PD-BT2238, ND-BT3814, and GD-BT6822, which are in discovery stage. It has research collaboration agreements with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.
Show more...
CEO
Gunilla Christina Osswald
Employees
131
Country
Sweden
ISIN
SE0010323311
WKN
000A2H5GS

Listings

STU
DE
B9A.STU
MU
DE
B9A.MU
ST
SE
BIOA-B.ST
OTC Link
US
BRCTF

0 Comments

Share your thoughts

FAQ

What is BioArctic AB stock price today?▼
The current price of BRCTF is $36.92 USD — it has increased by +8.44% in the past 24 hours. Watch BioArctic AB stock price performance more closely on the chart.
What is BioArctic AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange BioArctic AB stocks are traded under the ticker BRCTF.
Is BioArctic AB stock price growing?▼
BRCTF stock has risen by +10.01% compared to the previous week, the month change is a +16.19% rise, over the last year BioArctic AB has showed a +6.75% increase.
What is BioArctic AB market cap?▼
Today BioArctic AB has the market capitalization of 2.74B
When is the next BioArctic AB earnings date?▼
BioArctic AB is going to release the next earnings report on November 25, 2026.
What were BioArctic AB earnings last quarter?▼
BRCTF earnings for the last quarter are -0.01 USD per share, whereas the estimation was -0.03 USD resulting in a +61.19% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BioArctic AB revenue for the last year?▼
BioArctic AB revenue for the last year amounts to 204.09M USD.
What is BioArctic AB net income for the last year?▼
BRCTF net income for the last year is 101.78M USD.
Does BioArctic AB pay dividends?▼
Yes, BRCTF dividends are paid annual. The last dividend per share was 0.21 USD. As of today, Dividend Yield (FWD)% is 0.58%.
How many employees does BioArctic AB have?▼
As of September 04, 2026, the company has 131 employees.
In which sector is BioArctic AB located?▼
BioArctic AB operates in the Health & Wellness sector.
When did BioArctic AB complete a stock split?▼
BioArctic AB has not had any recent stock splits.
Where is BioArctic AB headquartered?▼
BioArctic AB is headquartered in Stockholm, Sweden.